VOCINBEQ
Live / Applied — Fifth extension granted (statement of use) (as of 11 Mar 2026)
What this means for you
Not registered yet, but its 22 Apr 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97377322
- Mark type
- Stylized text
- Filed
- 22 Apr 2022
- Published for opposition
- 21 Mar 2023
- Attorney of record
- Yana Gorbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of vaso-occlusive crisis; pharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions
Owner
- Global Blood Therapeutics, Inc., South San Francisco, CA, US
- Global Blood Therapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 12 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Mar 2026 — SOU EXTENSION 5 GRANTED
- 06 Oct 2025 — SOU EXTENSION 5 FILED
- 11 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 30 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 07 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Apr 2025 — SOU EXTENSION 4 GRANTED
- 28 Apr 2025 — SOU EXTENSION 4 FILED
- 28 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 16 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Oct 2024 — SOU EXTENSION 3 GRANTED